goldman sachs raises target on eli lilly: here's why
Published 2 months ago • 3.8K plays • Length 3:30Download video MP4
Download video MP3
Similar videos
-
0:50
goldman sachs raises recession likelihood by shocking percentage #shorts
-
5:20
goldman sachs' chris shibutani talks his top biotech picks including eli lilly and pfizer
-
4:51
goldman sachs raises price targets on big oil
-
3:46
goldman's peter oppenheimer: this correction is healthy and somewhat inevitable but may not be over
-
0:41
jim cramer on the huge potential for eli lilly's answer to ozempic #shorts
-
3:11
call of the day: eli lilly getting a price target boost at jefferies
-
7:42
former sec chair jay clayton on market sell-off, fed's inflation fight and google's antitrust ruling
-
3:58
eli lilly hits record high: here's what investors need to know
-
3:45
japanese market plunge driven by position unwinding around yen trade, says bleakley's boockvar
-
4:52
goldman sachs upgrades netflix to neutral rating with $400 price target, up from $225
-
2:32
cramer’s stop trading: goldman sachs
-
1:25
final trades: pfizer, eli lilly & gm
-
3:37
we expect energy prices to continue higher despite volatility, says goldman sachs's courvalin
-
57:50
why warren buffett dumped apple; watch this trigger for next big sell-off | jay singh
-
1:48
goldman sachs cuts apple price target from $187 to $165
-
3:56
committee stocks on the move: costco, eli lilly, netflix, google and gold
-
1:54
eli lilly to acquire morphic therapeutics for $3.2 billion in cash
-
5:05
would you rather buy nvidia or eli lilly? | guy adami on cnbc's fast money
-
5:10
goldman: risk of a 'growth shock' to equities increasing